KS

Kazumi Shiosaki

Managing Director at MPM Capital

Boston, Massachusetts

VC

Invests in

Stages:

Seed
Pre-seed

  • Min Investment:

    $0.00

  • Max Investment:

    $0.00

  • Target Investment:

    $0.00

Education

Lists including Kazumi

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

Investments

Twentyeight-Seven Therapeutics

Series A

Total Funding: $80M

Epizyme

Series B

Total Funding: $45M

Work Experience

MC
MPM Capital

  • Managing Director

Epizyme

2007 - 2010

  • CEO

    2007 - 2010

Primera

2004 - 2006

  • CEO

    2004 - 2006

MP
Millennium Pharmaceuticals

1997 - 2001

  • SVP Drug Discovery

    1997 - 2001